Comment
. 2012 Jan 20;30(3):334; author reply 335.
doi: 10.1200/JCO.2011.38.4701.
Epub 2011 Dec 12.
Fatal infusion reactions to cetuximab: role of immunoglobulin e-mediated anaphylaxis
- PMID: 22162592
- PMCID: PMC4908455
- DOI: 10.1200/JCO.2011.38.4701
Item in Clipboard
Comment
Fatal infusion reactions to cetuximab: role of immunoglobulin e-mediated anaphylaxis
J Clin Oncol.
.
No abstract available
Conflict of interest statement
The author(s) indicated no potential conflicts of interest.
Comment on
-
Fatal infusion reaction to cetuximab: the need for predictive risk factors and safer patient selection.J Clin Oncol. 2011 Aug 10;29(23):e680-1. doi: 10.1200/JCO.2011.35.5651. Epub 2011 Jun 20. J Clin Oncol. 2011. PMID: 21690469 No abstract available.
Similar articles
-
Managing drug infusion reactions: focus on cetuximab monoclonal antibody therapy.Clin J Oncol Nurs. 2008 Jun;12(3):530-2. doi: 10.1188/08.CJON.530-532. Clin J Oncol Nurs. 2008. PMID: 18515254 No abstract available.
-
Fatal infusion reaction to cetuximab: the need for predictive risk factors and safer patient selection.J Clin Oncol. 2011 Aug 10;29(23):e680-1. doi: 10.1200/JCO.2011.35.5651. Epub 2011 Jun 20. J Clin Oncol. 2011. PMID: 21690469 No abstract available.
-
Manage infusion reactions from cetuximab.ONS Connect. 2008 Sep;23(9):18-9. ONS Connect. 2008. PMID: 18807709 No abstract available.
-
[Molecular target therapy for colonic neoplasms].Nihon Naika Gakkai Zasshi. 2007 Feb 10;96(2):289-94. doi: 10.2169/naika.96.289. Nihon Naika Gakkai Zasshi. 2007. PMID: 17370595 Review. Japanese. No abstract available.
-
Cetuximab-associated infusion reactions: pathology and management.Oncology (Williston Park). 2006 Oct;20(11):1373-82; discussion 1382, 1392-4, 1397. Oncology (Williston Park). 2006. PMID: 17112000 Review.
Cited by
-
Delayed anaphylaxis to red meat in patients with IgE specific for galactose alpha-1,3-galactose (alpha-gal).Curr Allergy Asthma Rep. 2013 Feb;13(1):72-7. doi: 10.1007/s11882-012-0315-y. Curr Allergy Asthma Rep. 2013. PMID: 23054628 Free PMC article. Review.
-
Outpatient Emergencies: Anaphylaxis.Med Clin North Am. 2017 May;101(3):521-536. doi: 10.1016/j.mcna.2016.12.003. Epub 2017 Mar 2. Med Clin North Am. 2017. PMID: 28372711 Free PMC article. Review.
-
Engineering a therapeutic IgG molecule to address cysteinylation, aggregation and enhance thermal stability and expression.MAbs. 2013 Mar-Apr;5(2):255-62. doi: 10.4161/mabs.23392. Epub 2013 Feb 14. MAbs. 2013. PMID: 23412563 Free PMC article.
-
The role of IgE specific for galactose-α-1,3-galactose in predicting cetuximab induced hypersensitivity reaction: a systematic review and a diagnostic meta-analysis.Sci Rep. 2020 Dec 7;10(1):21355. doi: 10.1038/s41598-020-78497-7. Sci Rep. 2020. PMID: 33288791 Free PMC article.
-
Tick bites and red meat allergy.Curr Opin Allergy Clin Immunol. 2013 Aug;13(4):354-9. doi: 10.1097/ACI.0b013e3283624560. Curr Opin Allergy Clin Immunol. 2013. PMID: 23743512 Free PMC article. Review.
References
-
- Tronconi MC, Sclafani F, Rimassa L, et al. Fatal infusion reaction to cetuximab: The need for predictive risk factors and safer patient selection. J Clin Oncol. 2011;29:e680–e681. - PubMed
-
- Magdelaine-Beuzelin C, Kaas Q, Wehbi V, et al. Structure-function relationships of the variable domains of monoclonal antibodies approved for cancer treatment. Crit Rev Oncol Hematol. 2007;64:210–225. - PubMed
-
- O’Neil BH, Allen R, Spigel DR, et al. High incidence of cetuximab-related infusion reactions in Tennessee and North Carolina: Association with atopic history. J Clin Oncol. 2007;25:3644–3648. - PubMed
-
- George TJ, Jr, Laplant KD, Walden EO, et al. Managing cetuximab hypersensitivity-infusion reactions: Incidence, risk factors, prevention, and retreatment. J Support Oncol. 2010;8:72–77. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
